SKI Market

A+| A| A-|

Indian Indices

Sensex

75,315.04 77.05
( 0.10%)

Global Indices

Nasdaq

49,543.85 -540.61
(-1.08%)

Dow Jones

7,428.26 -93.98
(-1.25%)

Hang Seng

60,874.73 -534.56
(-0.87%)

Nikkei 225

10,297.25 101.88
(1.00%)

Forex

USD-INR

95.71 0.07
(0.07%)

EUR-INR

111.93 -0.13
(-0.12%)

GBP-INR

129.01 -0.31
(-0.24%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532531

INE939A01011

344.5797109

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

STAR

57.99

10636.73

EPS(TTM)

Face Value()

Div & Yield %

19.9

0.35

Date	Headline
18-May-2026	Board of Strides Pharma Science recommends final dividend
18-May-2026	Strides Pharma Science consolidated net profit rises 54.45% in the March 2026 quarter
18-May-2026	Strides Pharma Q4 PAT rises 54% YoY to Rs 127 crore
12-May-2026	Strides Pharma Science to hold board meeting
05-Feb-2026	Strides Pharma receives USFDA inspection closure report for its Chestnut Ridge facility
30-Jan-2026	Strides Pharma Science consolidated net profit rises 129.80% in the December 2025 quarter
30-Jan-2026	Strides Pharma Science jumps after strong Q3 performance
24-Jan-2026	Strides Pharma Science to conduct board meeting
26-Dec-2025	Strides Pharma slides as US arm receives 4 USFDA observations for New York facility
03-Dec-2025	Strides Pharma Science announces change in senior management

<< < 1 2 > >>

75,315.04 77.05 ( 0.10%)

49,543.85 -540.61 (-1.08%)

7,428.26 -93.98 (-1.25%)

60,874.73 -534.56 (-0.87%)

10,297.25 101.88 (1.00%)

95.71 0.07 (0.07%)

111.93 -0.13 (-0.12%)

129.01 -0.31 (-0.24%)

0.61 0.00 (-0.09%)